|
ZVRA Zevra Therapeutics Inc 1434647 |
| Balance Sheet |
|
Current Assets
|
$229,968,000.00 |
|
Assets
|
$278,579,000.00 |
|
Current Liabilities
|
$47,028,000.00 |
|
Liabilities
|
$72,775,000.00 |
|
Equity
|
$205,804,000.00 |
|
Shares Out
|
59114850.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$6,142,000.00 |
|
Investing Cash Flow
|
$79,618,000.00 |
| Market Analysis |
Market Cap
|
$569,867,154.00 |
|
Price
|
$9.57 |
|
BVPS
|
3.48 |
|
PB
|
2.77 |
|
EPS
|
0.62 |
|
PE
|
6.67 |
|
PS
|
5.70 |
|
FCF
|
$6,107,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:27 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:23 |
|
| Apr |
May |
Jun |
| 2026-03-09 |
0.19 |
|
|
2026-05-06 |
0.60 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-12 |
-0.06 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-05 |
-0.01 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view ZVRA documents filed with the SEC.
ZVRA Filings
Clear
